Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2003

Superoxide dismutase in clinical course of juvenile idiopathic arthritis

Med Sci Monit 2003; 9(4): 48-51 :: ID: 428637

Abstract

Background: The use of antioxidants as drugs that may control the inflammatory process in rheumatoid arthritis recently has become a widely studied hint. One of the most important components of antioxidant barrier in humans is enzyme superoxide dismutase (SOD). The experimental treatments with SOD were proved to be efficace in animals. The aim of the present study was to estimate the activity of SOD in patients with rheumatoid disease of childhood —juvenile idiopathic arthritis and to analyse it in different clinical aspects of the disease including its activity, course and time of duration. Material/Methods: A group of 68 children with JIA, aged from 3 to 18 years, patients of Rheumatologic Hospital in Sopot was examined in years 1996-2000. Juvenile idiopathic arthritis was diagnosed according to EULAR classification (Durban 1997). The control group consisted of 29 healthy children aged from 3 to 18 years. Superoxide dismutase activity was determined in full, heparinised blood with the use of spectrofotometric method of Randox. The study was accepted by the Local Comitee of Ethics.Results: A statistically important grow in SOD activity was found in group of children with JIA (2299.9 ±1773.1 U/gHb) com-pared to healthy group (1203 ±395.6 U/gHb). In polyarthricular form of disease the activity of SOD was also importantly higher than in control group.
Conclusions: In course of JIA, differently than in rheumatoid arthritis of adults, superoxide dismutase activity seems to be stimulated, so the treatment with egzogenous SOD may not be effective.

Keywords: juvenile idiopathic arthritis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750